Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
I Schwab, F Nimmerjahn - Nature Reviews Immunology, 2013 - nature.com
Intravenous immunoglobulin (IVIG) preparations comprise pooled IgG antibodies from the
serum of thousands of donors and were initially used as an IgG replacement therapy in …
serum of thousands of donors and were initially used as an IgG replacement therapy in …
Intravenous immune globulin in autoimmune and inflammatory diseases
EW Gelfand - New England Journal of Medicine, 2012 - Mass Medical Soc
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes
The rapid elimination of nanoparticles from the bloodstream by the mononuclear phagocyte
system limits the activity of many nanoparticle formulations. Here, we show that inducing a …
system limits the activity of many nanoparticle formulations. Here, we show that inducing a …
A case for regulatory B cells
A Mizoguchi, AK Bhan - The Journal of Immunology, 2006 - journals.aai.org
B cells are typically characterized by their ability to produce Abs, including autoantibodies.
However, B cells possess additional immune functions, including the production of cytokines …
However, B cells possess additional immune functions, including the production of cytokines …
Anti-inflammatory actions of intravenous immunoglobulin
The remarkable success story of the therapeutic application of pooled immunoglobulin G
(IgG) preparations from thousands of donors, the so-called intravenous IgG (IVIG) therapy, to …
(IgG) preparations from thousands of donors, the so-called intravenous IgG (IVIG) therapy, to …
Apoptosis in the anucleate platelet
V Leytin - Blood reviews, 2012 - Elsevier
For many years, programmed cell death, known as apoptosis, was attributed exclusively to
nucleated cells. Currently, however, apoptosis is also well-documented in anucleate …
nucleated cells. Currently, however, apoptosis is also well-documented in anucleate …
[HTML][HTML] Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
N Li, M Zhao, J Hilario-Vargas… - The Journal of …, 2005 - Am Soc Clin Investig
Numerous mechanisms of action have been proposed for intravenous Ig (IVIG). In this study,
we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus …
we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus …
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Despite a more than 20-year experience of therapeutic benefit, the relevant molecular and
cellular targets of intravenous immunoglobulin (IVIg) in autoimmune disease remain …
cellular targets of intravenous immunoglobulin (IVIg) in autoimmune disease remain …
The management of peripheral blood cytopenias in systemic lupus erythematosus
AL Hepburn, S Narat, JC Mason - Rheumatology, 2010 - academic.oup.com
Haematological complications are frequently seen in SLE. Anaemia, leucopenias and
thrombocytopenia may result from bone marrow failure or excessive peripheral cell …
thrombocytopenia may result from bone marrow failure or excessive peripheral cell …
Modulation of the cellular immune system by intravenous immunoglobulin
Intravenous immunoglobulin (IVIg) is therapeutically used in a variety of immune-mediated
diseases. The beneficial effects of IVIg in auto-antibody-mediated diseases can be …
diseases. The beneficial effects of IVIg in auto-antibody-mediated diseases can be …